By Deron Hamel A businessman is giving a presentation in a boardroom. Suddenly, he stops midspeech and begins to blankly stare. Then he starts to fidget and wander. One of his colleagues notices something is not right, but she has seen this before. She walks over to the man and slowly begins to guide him…
By Deron Hamel Epilepsy Ontario’s weekly column, the Voices of Epilepsy, saw strong readership in 2015, and of all the issues covered this year one received more buzz on the organization’s social-media platforms than any other: cannabidiol (CBD). CBD is a substance derived from the marijuana plant. It is the most abundant, non-psychoactive chemical compound…
By Deron Hamel A 2,000-per-cent price hike on a medication to treat infantile spasms is “predatory behaviour” on the part of Questcor Pharmaceuticals, and drug companies could hike prices on other seizure medications if policies aren’t put into place, says pediatric neurologist Dr. Carter Snead. Infantile spasms – also called West syndrome – is a…
By Deron Hamel It wasn’t long after Sarah Hysenaj had her first seizure that she became an epilepsy awareness advocate. Sarah was 11 years old and on a school field trip when she had her first seizure in front of her classmates. Fortunately for Sarah, her teacher knew exactly what was happening and what to…
Sponsor Image 1
Sponsor Image 2
Sponsor Image 3
Sponsor Image 1
Sponsor Image 2
